Article
Pediatric Oncology Provider Views on Performing a Biopsy of Solid Tumors in Children with Relapsed or Refractory Disease for the Purpose of Genomic Profiling.
Annals of surgical oncology - 1 Dec 2016
Cohen Barrie, Roth Michael, Marron Jonathan M, Gray Stacy W, Geller David S, Hoang Bang, Gorlick Richard, Janeway Katherine A, Gill Jonathan
Abstract excerpt
BACKGROUND: Patients with relapsed and refractory solid tumors have a poor prognosis. Recent advances in genomic technology have made it feasible to screen tumors for actionable mutations, with the anticipation that this may provide benefit to patients. METHODS: Pediatric oncologists were emailed an anonymous 34-question survey assessing their willingness to offer a rebiopsy to patients with relapsed disease for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
